Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Mallinckrodt
Moodys
Medtronic
AstraZeneca

Last Updated: January 25, 2022

DrugPatentWatch Database Preview

CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Chlordiazepoxide Hydrochloride And Clidinium Bromide patents expire, and when can generic versions of Chlordiazepoxide Hydrochloride And Clidinium Bromide launch?

Chlordiazepoxide Hydrochloride And Clidinium Bromide is a drug marketed by Alkem Labs Ltd, Amneal, Dr Reddys, Misemer, Nuvo Pharms Inc, Pharma Life, and Teva Pharms Usa. and is included in seven NDAs.

The generic ingredient in CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE is chlordiazepoxide hydrochloride; clidinium bromide. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the chlordiazepoxide hydrochloride; clidinium bromide profile page.

Summary for CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
US Patents:0
Applicants:7
NDAs:7
Finished Product Suppliers / Packagers: 9
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE?CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE excipients list
DailyMed Link:CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE at DailyMed
Drug patent expirations by year for CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
Pharmacology for CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
Anatomical Therapeutic Chemical (ATC) Classes for CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE

US Patents and Regulatory Information for CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE

CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE is protected by zero US patents and one FDA Regulatory Exclusivity.

FDA Regulatory Exclusivity protecting CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE

COMPETITIVE GENERIC THERAPY
Exclusivity Expiration: ⤷  Try it Free

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Colorcon
AstraZeneca
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.